Dallas Salazar
IPOs, contrarian, long/short equity, long-term horizon

Castlight Health's Bizarre IPO Pricing And Recent Panic Selling Are Just Two Parts Of A Horrible Story

Castlight Health Inc. (NYSE:CSLT) held one of the most bizarre IPO's of recent memory on 3/14/2014 selling 11,100,000 shares of B Class stock at $16/share, which was above their $13-$15 initial projected range. Goldman Sachs and Morgan Stanley were the main underwriters handing the IPO.

Although on the surface nothing about the IPO seems unusual it becomes borderline bizarre when considering that the $16 pricing gave CSLT, a company who at the time had 2013 revenues of $13 million, net losses of $62 million, and an accumulated deficit of $131.2 million, a $1.5 billion valuation. Yes, billion. Had this valuation stood the company would have been valued at over 100x revenues, a statistic that I have come to...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details